These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19826875)

  • 1. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas.
    Itoh S; Morita K; Ueda S; Sugimachi K; Yamashita Y; Gion T; Fukuzawa K; Wakasugi K; Taketomi A; Maehara Y
    Ann Surg Oncol; 2009 Dec; 16(12):3299-307. PubMed ID: 19826875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series.
    Kim YS; Rhim H; Lim HK; Choi D; Lee WJ; Jeon TY; Joh JW; Kim SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1862-70. PubMed ID: 18463926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?
    Chirica M; Scatton O; Massault PP; Aloia T; Randone B; Dousset B; Legmann P; Soubrane O
    Arch Surg; 2008 Jun; 143(6):538-43; discussion 543. PubMed ID: 18559745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting treatment for hepatocellular carcinoma based on the results of hepatic resection and local ablation therapy.
    Nanashima A; Tobinaga S; Masuda J; Miyaaki H; Taura N; Takeshita H; Hidaka S; Sawai T; Nakao K; Nagayasu T
    J Surg Oncol; 2010 May; 101(6):481-5. PubMed ID: 20191611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of patients with intrahepatic recurrence after hepatic resection for hepatocellular carcinoma: a retrospective study.
    Kawano Y; Sasaki A; Kai S; Endo Y; Iwaki K; Uchida H; Shibata K; Ohta M; Kitano S
    Eur J Surg Oncol; 2009 Feb; 35(2):174-9. PubMed ID: 18325724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma.
    Nicoli N; Casaril A; Marchiori L; Mangiante G; Marini G; Colombari R; Portuese A; Hasheminia AR
    Chir Ital; 2000; 52(1):29-40. PubMed ID: 10832524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraoperative radiofrequency ablation and 125I therapy for preventing local recurrence in hepatocellular carcinoma after hepatectorny].
    Chen KY; Xiang GA; Wang HN; Xiao FL
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):626-8. PubMed ID: 18210887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database.
    Ng KK; Vauthey JN; Pawlik TM; Lauwers GY; Regimbeau JM; Belghiti J; Ikai I; Yamaoka Y; Curley SA; Nagorney DM; Ng IO; Fan ST; Poon RT;
    Ann Surg Oncol; 2005 May; 12(5):364-73. PubMed ID: 15915370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of postoperative recurrence of hepatocellular carcinoma with radiofrequency ablation comparing with repeated surgical resection].
    Ren ZG; Gan YH; Fan J; Chen Y; Wu ZQ; Qin LX; Ge NL; Zhou J; Xia JL; Wang YH; Ye QH; Wang L; Ye SL
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1614-6. PubMed ID: 19094752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection.
    Pandey D; Lee KH; Wai CT; Wagholikar G; Tan KC
    Ann Surg Oncol; 2007 Oct; 14(10):2817-23. PubMed ID: 17690940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma.
    Kobayashi M; Ikeda K; Kawamura Y; Yatsuji H; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
    Cancer; 2009 Feb; 115(3):571-80. PubMed ID: 19117347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
    Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
    Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.